U.S. Agencies Focusing On Urban Remediation

The 'environmental justice' movement presses for studies of links among poverty, exposure to toxins, and disease. A collaborative effort is under way to assess the legacy of environmental pollution that falls upon the poor. An Institute of Medicine (IoM) committee recently completed site visits as part of its 18-month study that will evaluate the research, educational, and health policy needs required to bring "environmental justice" to impoverished and minority communities. Environmental just

Written byMyrna Watanabe
| 10 min read

Register for free to listen to this article
Listen with Speechify
0:00
10:00
Share

The 'environmental justice' movement presses for studies of links among poverty, exposure to toxins, and disease. A collaborative effort is under way to assess the legacy of environmental pollution that falls upon the poor. An Institute of Medicine (IoM) committee recently completed site visits as part of its 18-month study that will evaluate the research, educational, and health policy needs required to bring "environmental justice" to impoverished and minority communities. Environmental justice involves seeking remedies for health problems that advocates say disproportionately affect poor and minority populations living in industrial or urban areas. Funding support for the IoM study is provided by the Centers for Disease Control and Prevention (CDC), the Department of Energy (DOE), the Environmental Protection Agency (EPA), and the National Institutes of Health. The undertaking is one of several recent efforts to investigate issues related to environmental justice. In the meantime, communities have taken matters into their ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies